Coronavirus Disease 2019 (COVID-19) declared a global pandemic by World Health Organization (WHO) in March 2020 after spread in many countries. Cases with this severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) present with various clinical sign and symptoms. Inflammation reported in covid-19 cases and play a major role in progression of covid-19. Neutrophil to Lymphocyte Ratio (NLR) is one of many biomarkers of inflammation which can be obtained from Complete Blood Count by dividing neutrophil and lymphocyte count. This change in NLR levels is an important biomarker to asses covid-19 severity and progression of disease. Previous articles found that NLR in covid-19 patients have a tendency to increased.